In mice and rats, treatment of severe anemia associated with CRF with Epo-gene electrotransfer, where hematocrit levels were similar to those in humans with end-stage renal disease, resulted in increased Epo and hematocrit levels [43,44]. This evidence concerns the gene EPO and stage 5 chronic kidney disease.